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Bipolar Disorder
Heather Guthrie BSN, RN
Otterbein University, Westerville, Ohio
Introduction
Bipolar affective disorder (BAD) is a
mood disorder that causes severe shifts
in mood, energy, concentration, and
activities of daily living. Bipolar used to
called manic-depressive disorder or
manic depression (NIMH, 2020). BAD
mood swings range from deep, low
depression to severe euphoric-like mania
with normal periods in between. Some
patients with BAD experience delusions
and hallucinations that lead to an
impairment of the cognitive, behavioral
and affective bodily functions (de Sousa
Moura et al., 2019).
Bipolar disorder is divided into type I
(BDI), type II (BDII), and cyclothymic
disorder (cyclothymia) (“NIMH bipolar
disorder”, 2020). Type I is characterized
by mood elevation in a severe and
persistent manner (mania), and deep
depression episodes in between with
normalcy. Type II is characterized by
mild elevation of mood (hypomania) that
the patient might even know something
is different, and a major depressive
episode (Moura et al., 2019).
Cyclothymic disorder is described as
periods of hypomania with depressive
symptoms lasting longer than 2 years,
but meeting the standards of BDII
(“NIMH bipolar disorder”, 2020). BDII
was finally recognized as a “real
disorder” in 1994 by the Diagnostic and
Statistical Manual of Mental Disorders
because mood disorders have a variety of
symptoms that are not classified within
certain categories. Within BDI, every
system is affected and strained to the
limits. While BDII some symptoms are
more susceptible than others to the
extreme (Gitlin and Malhi, 2020).

Mood Disorder
Questionnaire
(MDQ)
The Mood Disorder Questionnaire
(MDQ) is an established tool utilized
throughout the medical field. MDQ was
developed by a team of psychiatrist and
researchers to address a critical need for
timely and accurate diagnosis of bipolar
disorders (“NIMH bipolar disorder”,
2020). This tool is a self-reporting
questionnaire that focuses on
recognitions and occurrence of bipolar
disorder signs. MDQ is used as an
clinical and nonclinical psychiatric
evaluation tool that utilizes all bipolar
spectrum disorders. The questionnaire
utilizes 13 questions regarding mood,
activity level, and behaviors, whether
symptoms occur together, and if
symptoms cause trouble with everyday
life. Scoring include 7 positive answers
in question , positive answer to question
2, and a moderate to severe answer to
question 3 (Dumont et al., 2020).

Underlying Pathophysiology
Connected to the Brain

Pathophysiology
The pathophysiology of
bipolar disorder is widely
unknown due to no genetic or
biologic markers being
identified specifically for
bipolar. However, studies have
shown a familial tendency
suggests that the correlation
between a parent with BAD will
have a higher percentage a child
that could have BAD. Also, twins
have an estimated 85% of
inheritability of BAD. Even
among adoptees with a biologic
family history correlates to a
strong incidence of developing
BAD. Genetic studies suggest
that chromosomal and genes are
related to BAD with a mild or
moderated effect. However,
clinical symptoms have a direct
link to developmental and
environmental factors are just
as important as genetic factors
(Sigitova et al., 2017).

Neurodevelopment is a vital
component regarding the inception of
bipolar disorder. Studies suggest that
neurocognitive deficits or dysfunction
occur during and after the first mood
episode (Kloiber et al., 2020). Chronic
neuroinflammation,, caused by aging,
traumatic brain injuries, viruses, and
autoimmunity, are associated with BAD
(Stgitova et al., 2017). Dopamine, which
is referred as the “reward
neurotransmitter”, regulates behavioral
activation by increasing or decreasing
behavioral energy within the body
(Mansur et al., 2020).

The brain changes slightly
during episodes of mania and
depression. Thus, brain
structure/function differs between
BDI and BDII. Cognitive
impairment has been shown during
the euthymic periods during
bipolar. Frontal lobe thickness has
a direct correlation with executive
function (Abe et al., 2018).

Implication of Nursing Care
Education is the key to living with bipolar disorder. The suicide rate with
bipolar patients are the higher than other psychiatric diagnosis. Substance abuse
and other comorbid also impact people living with bipolar disorder (Katz et al.,
2020). Prejudice and discrimination still occur negatively about mental health
issues. Education is the key for the patients, families, care givers, and society to help
understand and explain to eliminate stigma, fear, and prejudice. Support networks
will help minimize caregiver burnout, and promote healthy, safe, and affective
treatment (Maura et al., 2019).
There are a vast amount of treatment options for patient’s living with bipolar
disorders. Some of these options are: lithium (medication most commonly used),
psychotherapy (“talk therapy”), electroconvulsive therapy (ECT), and transcranial
magnetic stimulation (TMS). Since BAD is a life-long illness, managing symptoms
with continuous treatment is the best option for all patients (“NIMH bipolar
disorder”, 2020).

Proper diagnosis is key to
help the patients succeed to
have a safe, healthy life. Usually,
diagnosis of BAD is by the
patient’s symptoms, history, and
experiences. Accurate diagnosis
is vital especially in young
patients (“NIMH bipolar
disorder”, 2020).

Signs and Symptoms

Depression









Feeling very sad or hopeless
Talking slowly, forgetfulness, or
having nothing to say
No sex drive or inability to
experience pleasure
Trouble doing simple tasks
Not having any energy or restless
Feeling like you cannot enjoy
anything
Trouble concentrating or making
decisions
Thinking about death or suicide
(“NIMH bipolar disorder”, 2020)

Mania












Feeling very high, elated, or irritable
or touchy
Elevated or irritated mood
Loss of appetite
Increase activity or restlessness
Feelings of jumpiness or wired
Racing thoughts or talking fast
Think like they can do many tasks at
once
A decreased need for sleep
Poor judgement or risky behavior
Feeling of importance, talented, or
powerful
(“facts on bipolar disorder and FDAapproved treatment”, 2017)

Conclusion
Bipolar disorder is a life altering diagnosis that not only affect the patient but
everyone in that person’s life. Many struggles arise with trying to control
symptoms so the patient has a quality of life beside a BAD diagnosis. Treatment
options are patient specific and many trials might need acquired to find the right
treatment. Poor judgement, self-harm, and erratic behavior can increase the risk
for suicide, substance abuse, and death. Education is vital to reduce the stigma
living with a mental health disorder. Acceptance from the community and
society has a enormous capacity to encourage honesty with bipolar diagnoses.

